Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung (Non-Small Cell)
Study Phase
Phase 3
Study Completion Date
June 2013
NCT00533949Uploaded 01-30-2018
Access via NCI by Request
PDS UID: nci-data-361
A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer
Files: NCT00533949-D3
Data DictionaryNCT00533949-D3-Data-Dictionary.pdf
DATANCT00533949-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT00533949-D2
Data DictionaryNCT00533949-D2-Data-Dictionary.pdf
DATANCT00533949-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00533949-D1
Data DictionaryNCT00533949-D1-Data-Dictionary.pdf
DATANCT00533949-D1-Dataset.csv
OTHERREADME.pdf